Please assess the completion status of the following clinical trial:

Trial Title: Transcranial Magnetic Stimulation to Improve Speech in Aphasia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Right Handed~* Single, Left Hemisphere Cerebrovascular Stroke~* Must be at least 6 months poststroke onset~* Native Speaker of English~* Clinical Diagnosis of Aphasia~Exclusion Criteria:~* Intracranial metallic body from prior neurosurgical procedure~* Implanted metallic devices: pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit or ventriculoperitoneal shunt~* Past history of seizure within 1 year~* Pregnancy~* History of substance abuse within last 6 months

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Real rTMS (Type: EXPERIMENTAL): These patients receive a series of 10 Real Transcranial Magnetic Stimulation, Repetitive (rTMS), treatments, only. There is pre-testing, and post-testing at 2 months after the last Real rTMS treatment.
- Sham rTMS (Type: SHAM_COMPARATOR): Patients receive a series of 10 Sham Transcranial Magnetic Stimulation, Repetitive (rTMS) treatments, followed by a series of 10 Real rTMS treatments. Sham rTMS treatments are identical to the Real rTMS treatments, however, no magnetic pulse is released. There is pre-testing, and post-testing at 2 months after the last Sham rTMS treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).